NextCure NXTC
NASDAQ NXTC
$4.71 -0.70 (-13.21%)
As of: Oct 22, 2026 · 3:59 PM EDT

NextCure (NXTC) Depreciation & Amortization (CF) (2018 - 2026)

Updated

NextCure's Depreciation & Amortization (CF) came in at $272,000 for Q2 2026, down 57.0% from $633,000 a year earlier and down 3.9% from the prior quarter.

Analysis

NextCure (NXTC) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, NextCure reported Depreciation & Amortization (CF) of $1.47 million, down 45.5% year-over-year; for FY2025, it was $2.2 million, down 24.1% from FY2024.

  • Depreciation & Amortization (CF) has declined in each of the last four years, with a five-year compound annual growth rate of -8.4% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $2.9 million in FY2024 (-21.6%), $3.7 million in FY2023 (-10.3%), $4.12 million in FY2022 (-4.1%) and $4.3 million in FY2021 (+26.0%).
  • The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) in data going back to Q1 2018.
  • Year-over-year, Depreciation & Amortization (CF) has declined for 16 consecutive quarters, with an average decline of 31.6% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q2 2022 (growth of 259.2%), and the weakest in Q2 2026 (a decline of 57.0%).
  • Business Quant data shows NXTC's Depreciation & Amortization (CF) at $283,000 (Q1 2026), $380,000 (Q4 2025) and $533,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 534.00 Mn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 2.12 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 194.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 599.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.93 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 1.11 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 98.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 1.62 Bn
10 NextCure 25.27 Mn -95.48 Mn - 272,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 272,000.00
Mar 31, 2026 283,000.00
Dec 31, 2025 380,000.00
Sep 30, 2025 533,000.00
Jun 30, 2025 633,000.00
Mar 31, 2025 654,000.00
Dec 31, 2024 709,000.00
Sep 30, 2024 700,000.00
Jun 30, 2024 701,000.00
Mar 31, 2024 790,000.00
Dec 31, 2023 840,000.00
Sep 30, 2023 946,000.00
Jun 30, 2023 954,000.00
Mar 31, 2023 960,000.00
Dec 31, 2022 1.01 Mn
Sep 30, 2022 1.02 Mn
Jun 30, 2022 1.04 Mn
Mar 31, 2022 1.06 Mn
Dec 31, 2021 1.16 Mn
Sep 30, 2021 1.74 Mn
API Access

NextCure Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NXTC&period=max&api_key=YOUR_API_KEY